Literature DB >> 26849164

Current laboratory approaches to diagnosis of CNS fungal infections.

Jennifer L Lyons1, Sean X Zhang2,3.   

Abstract

Entities:  

Keywords:  (1,3) β-d-glucan; CNS; cerebrospinal fluid; fungal infection; molecular testing

Mesh：

Substances：

Year:  2016        PMID： 26849164     DOI： 10.2217/fmb.15.138

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  4 in total

Review 1.  Diagnosing Invasive Candidiasis.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

2.  Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review.

Authors:  Christian Davis; L Joseph Wheat; Thein Myint; David R Boulware; Nathan C Bahr
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.

Authors:  Stefan Schwartz; Oliver A Cornely; Kamal Hamed; Francisco M Marty; Johan Maertens; Galia Rahav; Raoul Herbrecht; Werner J Heinz
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

4.  Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.

Authors:  Giancarlo Ceccarelli; Maria Cristina Ghezzi; Giammarco Raponi; Grazia Brunetti; Carolina Marsiglia; Stefania Fallani; Andrea Novelli; Mario Venditti
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.